Financial statements Nextpharm
Balance sheet of Nextpharm
Company age:
Age:
15 y. 3 m. 28 d.
Share capital:
Share capital:
5 000 PLN
Company suspended its operations from 2024-03-01
Balance sheet data of NEXTPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 678 234,21 | 408 587,82 | 425 365,01 | 424 571,60 | 116 194,08 | 118 729,84 |
| A. Fixed assets | 401 586,82 | 401 586,82 | 401 586,82 | 401 586,82 | 105 829,47 | 105 829,47 |
| B. Current assets | 276 647,39 | 7 001,00 | 23 778,19 | 22 984,78 | 10 364,61 | 12 900,37 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | - | - |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | - | - |
| Total liabilities | 678 234,21 | 408 587,82 | 425 365,01 | 424 571,60 | 116 194,08 | 118 729,84 |
| A. Equity | 401 057,36 | 145 054,66 | 135 476,02 | 130 958,45 | 97 213,38 | 89 245,78 |
| B. Liabilities and provisions for liabilities | 277 176,85 | 263 533,16 | 289 888,99 | 293 613,15 | 18 980,70 | 29 484,06 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 206 676,49 | 237 095,51 | 263 451,34 | 267 175,50 | 18 980,70 | 29 484,06 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.